chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 6.0
Sex: M
Vaccine: DTAPHEPBIP, FLU3, HIBV, PNC, RV5
Symptoms: Body temperature increased, Inappropriate schedule of drug administration, Irritability, Lacrimation increased, Medication error
Clinical narrative: Pt is a 6 m male with irritability early this morning, had non-rhythmic shaking movements of upper and lower extremities without organization, seemed chilled to mother though body was hot; a pool of spittle nearby, but that is not abnl for him, as he is teething; Mother states eyes appeared somewhat glazed, period lasted about 2 minutes, and when ended, he seemed more placid and restful; he fell asleep shortly after and awakened his usual time of 6 AM and has seemed normal since, though felt a bit warm on awakening and given infant advil; he fed well at 6 AM; Pt seen yesterday for WB visit and was no ill; he was given flu, Pediarix, HIB and Prevnar, Rotateq, he had had all of these x2 prior, with exception of flu; At 3 months, prior to coming to this area, he had 103 documented temp within 24 hrs of 1st immunizations, consisting of Combivax, DTaP, Prevnar and Rotateq; no intervention required and no sequelae; Pt without perinatal or dev concerns and no fam hx of epilepsy or neurological problems
Age: 6.0
Sex: M
Vaccine: DTAPHEPBIP, FLU3, HIBV, PNC, RV5
Symptoms: Skin warm, Tremor
Clinical narrative: Pt is a 6 m male with irritability early this morning, had non-rhythmic shaking movements of upper and lower extremities without organization, seemed chilled to mother though body was hot; a pool of spittle nearby, but that is not abnl for him, as he is teething; Mother states eyes appeared somewhat glazed, period lasted about 2 minutes, and when ended, he seemed more placid and restful; he fell asleep shortly after and awakened his usual time of 6 AM and has seemed normal since, though felt a bit warm on awakening and given infant advil; he fed well at 6 AM; Pt seen yesterday for WB visit and was no ill; he was given flu, Pediarix, HIB and Prevnar, Rotateq, he had had all of these x2 prior, with exception of flu; At 3 months, prior to coming to this area, he had 103 documented temp within 24 hrs of 1st immunizations, consisting of Combivax, DTaP, Prevnar and Rotateq; no intervention required and no sequelae; Pt without perinatal or dev concerns and no fam hx of epilepsy or neurological problems
Age: 1.0
Sex: F
Vaccine: FLUN3, HIBV, MMR, PNC, VARCEL
Symptoms: Inappropriate schedule of drug administration, Medication error, Wrong drug administered
Clinical narrative: Child was given Flumist instead of injectable flu vaccine for 6-36 months; There were no adverse effects, but the wrong kind of flu was given for the wrong age, doctor said to report
Age: 52.0
Sex: F
Vaccine: TDAP
Symptoms: Dyspnoea, Injection site erythema, Injection site pain, Injection site swelling, Lethargy
Clinical narrative: Pain, redness, swelling at injection site, lethargy, Rash on (R) elbow began 12/15/07, now resolved (resolved 6 hr 12/19/07) 12/23/07 shortness of breath after walking outdoors, rash on bilateral palms. Unresolved as of 12/26/07. No hives, itching, or tachycardia per patient.
Age: 52.0
Sex: F
Vaccine: TDAP
Symptoms: Rash
Clinical narrative: Pain, redness, swelling at injection site, lethargy, Rash on (R) elbow began 12/15/07, now resolved (resolved 6 hr 12/19/07) 12/23/07 shortness of breath after walking outdoors, rash on bilateral palms. Unresolved as of 12/26/07. No hives, itching, or tachycardia per patient.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Joint stiffness, Limb discomfort, Paraesthesia
Clinical narrative: Tingling in sore arm as shots with Hep A and menactra.  Also tightness at elbow.  PE: good strength, reflexes, light touch sensation variable below elbow.
Age: 15.0
Sex: M
Vaccine: MNQ
Symptoms: Body temperature increased, Headache, Nausea
Clinical narrative: Had annual PE on 12-11-07 afternoon.  Well adolescent.  12-12-07, 10 am family called, client experiencing severe headache with nausea.  Temp between 100.1 to 100.8.  Instructed to go to most convenient ped. hosp er - chose AI Dept.  Moderate distress from headache.  Dx: headache 2 hours to Menactra side effects.
Sex: F
Vaccine: HPV4
Symptoms: Dyspnoea, Hyperhidrosis, Injection site pain, Pain in extremity, Sleep disorder
Clinical narrative: Patient complained of severe injection site pain, shortness of breath, sweats.  Arm soreness for several days.  Awakened patient from sleep right after injection.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Cyanosis, Electroencephalogram normal, Syncope, Tonic clonic movements
Clinical narrative: Patient had syncope with cyanosis and tonic-clonic UE jerks.  Prescribed with ammonia smelling salts and 02 by mask briefly.  No sleepiness post.  No bowel or bladder disturbances.
Age: 0.43
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Erythema, Rash
Clinical narrative: Mother called in 12/19/07 and stated that her son has developed red spots on his back and belly. States they are "hand" size. Unclear as to how long after shots baby developed the "red spots." Advised to seek emergency care since baby has no PCP.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Pain & soreness on arm in area of vaccine for the last 5 weeks.  Hurt to raise arm over head, lift or carry objects.  Currently taking Aleve twice daily for 10 days.
Age: 27.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect route of drug administration, Medication error
Clinical narrative: IM influenza vaccine was mistaken for "Flu Mist" and administered to the nasal passage as a liquid. Once mistake was determined it was given IM
Age: 19.0
Sex: M
Vaccine: FLU3, HEP
Symptoms: Incorrect route of drug administration, Medication error
Clinical narrative: IM Influenza vaccine was mistaken for "Flu Mist" and administered to the nasal passage as a liquid. One mistake was determined it was given IM
Age: 18.0
Sex: U
Vaccine: FLU3, HEP, HEPA
Symptoms: Incorrect route of drug administration
Clinical narrative: IM influenza vaccine was mistaken for "Flu Mist" and administered to the nasal passage as a liquid. Once mistake was determined it was given IM
Age: 0.9
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Urticaria to all body on next day after administration of Fluzone vaccine.
Age: 0.3
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Abscess drainage, Injection site abscess
Clinical narrative: 3 month old female developed abscess at site of immunization - right thigh - seen 12/29/07 abscess 2 cm in diameter - drainage 1 day - rechecked 12/31/07 abscess decreased to 1 1/4 cm.  Drainage stopped.  Rx: Augmentin 4004 5ml 4ml bid x 10 days 12/29/07.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Blood test, Erythema of eyelid, Eyelid oedema, Swelling face
Clinical narrative: Pt reports redness and swelling to face and eyelids red and puffy. Saw PMD on 12/3/07 and was sent for blood work. Possible allergies to Satsuma trees, foods.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Local swelling, Lymphadenopathy, Pain
Clinical narrative: Local swelling, swollen lymph nodes, localized pain.
Age: 4.0
Sex: M
Vaccine: DTAP, FLU3, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Erythematous and edematous area 6 3/4in by 5 3/4in on right thigh.  No breaks in skin.  Even this has become erythematous, has increased today.
Age: 0.18
Sex: M
Vaccine: DTAPHEPBIP, FLU3, HIBV, PNC, RV5
Symptoms: Wrong drug administered
Clinical narrative: Flu vaccine was administered in error by MA. Medical director notified. No adverse reaction. Parents notified of error.
Age: 76.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Injection site scab, Scab, Skin exfoliation
Clinical narrative: One week following shot area scaling, then scabs for 3 weeks. Still has redness 1-2-08; small red area. No itching no fever, no aching.
Age: 0.8
Sex: F
Vaccine: FLU3
Symptoms: Incorrect dose administered
Clinical narrative: Patient given wrong dose of flu.  0.5 ml instead of 0.25 ml.  Called CDC for instructions, give 2nd dose, 4 wks age appropriate dose.
Age: 77.0
Sex: F
Vaccine: FLU3
Symptoms: Full blood count normal, Injection site bruising, Injection site haemorrhage, International normalised ratio, X-ray normal
Clinical narrative: Patient arrives 12/11/07 s/p flu shot at Heritage.  11/7/07 patient reported bruising at site since 11/9/07 x 2 weeks with return ecchymosis with INR drawn on 12/5/07.  X-ray: negative foreign body, negative fx, negative bursitis.  Labs: CBC nl except hot 35.1 (Sl down), INR 2.4/Plat 252.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Dyspnoea, Nausea, Pain in extremity
Clinical narrative: About 15-18 hours after vaccine, shortness of breath, dizziness, nausea, arm soreness.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Unevaluable event
Clinical narrative: No adverse events
Age: 1.3
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Injection site vesicles
Clinical narrative: Onset of area on (L) thigh that looked liked a bug bite that progressed to vesicles over the next several days.
Age: 1.4
Sex: F
Vaccine: DTAP, MMR, VARCEL
Symptoms: Injection site vesicles, Rash
Clinical narrative: Vesicular lesions at site of injection left thigh, truncal rash. Both 10 days after immunization. Tylenol - observation - comfort measures.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: 9 x 8 cm, red, warm red area (L) upper arm at site of injection.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Swelling, redness, tenderness at injection site; onset 2-4 hours after injection. Persistent 5 cm square reaction on 12/28/07.
Age: 8.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Fall, Syncope
Clinical narrative: About 5 min after immunizations were given the pt was standing and fainted. He fell and Mom and sister were the only ones in the room with him. We heard Mom yell for help and we ran in the room and had him lay on the floor. He sat in the office for 1 hr. After while he ate sugar and drank fluids and he was good after that.
Age: 26.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 24.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax Lot #FAV110 Administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per Milvax direction.
Age: 30.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax Lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per Milvax direction.
Age: 27.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per MILVAX direction.
Age: 24.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax Lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per Milvax direction.
Age: 33.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per MILVAX direction.
Age: 29.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax Lot #FAV110 Administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per Milvax direction.
Age: 28.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax Lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per Milvax direction.
Age: 32.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 38.0
Sex: F
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per agency direction.
Age: 43.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax Lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per Milvax direction.
Age: 29.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 40.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax Lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per Milvax direction.
Age: 33.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax Lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per Milvax direction.
Age: 45.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 40.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 28.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 26.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 27.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 19.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 30.0
Sex: F
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 39.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per milvax direction.
Age: 37.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot# FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per Milvax direction.
Age: 23.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 31.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot# FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per milvax direction.
Age: 30.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 20.0
Sex: F
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 20.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per milvax direction.
Age: 42.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 37.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 22.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 20.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 41.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 31.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 25.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 23.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 24.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 32.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 34.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 46.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 22.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 18.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 34.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 20.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 39.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 39.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 33.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 31.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 19.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 18.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 28.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 36.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 30.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 35.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 24.0
Sex: F
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 27.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 23.0
Sex: F
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 31.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 18.0
Sex: F
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 44.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 36.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered, No adverse reaction
Clinical narrative: Anthrax Lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per agency direction.
Age: 19.0
Sex: F
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 33.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 18.0
Sex: F
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time.  Report submitted per authority direction.
Age: 36.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 22.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per milvax direction.
Age: 38.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot #FAV110 administered after expired date due to administrative oversight.  No adverse reaction at this time.  Report submitted per authority direction.
Age: 45.0
Sex: M
Vaccine: ANTH
Symptoms: Expired drug administered
Clinical narrative: Anthrax lot # FAV110 administered after expired date due to administrative oversight. No adverse reaction at this time. Report submitted per MILVAX direction.
Age: 40.0
Sex: M
Vaccine: ANTH
Symptoms: Erythema, Influenza, Lethargy, Oedema, Rash macular
Clinical narrative: Pt developed edema and erythema extending to elbow.  Developed macular rash, no urticaria.  Lethargy, flu-like symptoms.  Symptomatic treatment with diphenhydramine.
Age: 21.0
Sex: F
Vaccine: ANTH
Symptoms: Oedema, Pruritus, Rash
Clinical narrative: 12/26/07 Vaccination (R) arm. 12/27/07 - Local edema with TTP, no adenopathy, + rash upper torso with pruritus, no SOB, no peripheral edema other than noted.
Age: 10.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Erythema, Pain, Rash, Skin warm
Clinical narrative: Patient received the varicella vaccination in his left deltoid on 12-14-07.  On 12-15-07 mom noticed he had a small rash and by 12-17-07 the redness was 60 mm.  Patient said it was painful to the touch and it feels hot, he also stated putting ice on the arm doesn't help, it hurts.
Age: 59.0
Sex: F
Vaccine: TD, TD
Symptoms: Arthralgia, Injection site erythema, Injection site swelling, Lymphadenopathy
Clinical narrative: Localized rxn.  Had stepped on a foreign body and was given a tetanus/diphtheria booster since pt had not had a booster within past 10 years on 10/4/07.  She had localized swelling and redness of left arm at the injection site & joint achiness, no breathing difficulty.  2 x 3 cm redness on left upper arm.  Pt given Decadron/Deponechol injection 10/8/07.  Reaction eventually resolved, lower axillary lymph node & left axillary wall lymph node persisted in being enlarged slightly.
Age: 59.0
Sex: F
Vaccine: TD, TD
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Localized rxn.  Had stepped on a foreign body and was given a tetanus/diphtheria booster since pt had not had a booster within past 10 years on 10/4/07.  She had localized swelling and redness of left arm at the injection site & joint achiness, no breathing difficulty.  2 x 3 cm redness on left upper arm.  Pt given Decadron/Deponechol injection 10/8/07.  Reaction eventually resolved, lower axillary lymph node & left axillary wall lymph node persisted in being enlarged slightly.
Age: 1.5
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Induration, Pyrexia
Clinical narrative: Dtap #3 (Sanofi - Lot #U2354CA) given on 12/12/07.  Entire left thigh erythema, not painful, indurated with some increased adenopathy, fever 101 on 12/13/07.
Age: 22.0
Sex: M
Vaccine: HEP, HEPA
Symptoms: Unevaluable event
Clinical narrative: No adverse events. Adult was vaccinated with pediatric dose of hepatitis B Engerix B.
Age: 29.0
Sex: M
Vaccine: HEP, HEPA
Symptoms: No adverse reaction
Clinical narrative: No adverse events.  Adult was vaccinated with pediatric dose of Hepatitis B Engerix B.
Age: 29.0
Sex: M
Vaccine: HEP
Symptoms: No adverse reaction
Clinical narrative: No adverse events.  Adult was vaccinated with pediatric dose of Hepatitis B Engerix B.
Age: 68.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Cellulitis, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Client states that he experienced pain, redness and swelling at injection site a few hours after vaccination on 11/19/07. He went to the emergency room on 11/21/07 due to worsening condition at the injection site. He stated he was treated with IV antibiotics for cellulitis and put on an oral course of antibiotics with an uneventful recovery.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Blood calcium normal, Blood cholesterol normal, Blood creatinine increased, Blood electrolytes increased
Clinical narrative: Complaints of numbness and tingling in the feet, generalized weakness that started several days prior to admission.  The patient's initial symptoms were mild but progressively worsened which prompted her to seek medical attention.  The patient did have a fall at home.  1/18/08 Reviewed hospital medical records which reveal patient experienced progressive generalized weakness & falls x 5-6 days prior to admit w/tingling in bilateral legs which progressed to involve tongue & fingers. Admitted 11/28-12/06/2007 to ICU for respiratory concerns.  On exam DTRs absent, unsteady gait, decreased sensation.  Neuro, Renal, Psych & ST consults done.  Tx w/plasmapheresis x 5.  While hospitalized, developed Bell's palsy.  Slow improvement & transferred to inpatient rehab 12/6-12/14/2007 for continued PT/OT.  Not much progress until received 2 more plasmapheresis treatments while in rehab, then progressed well.  D/C to home w/PT, Neuro & pcp f/u as outpatient. FINAL DX: Guillain-Barre syndrome. 1/24/08 Received EMG/NCS report of 11/29/07 which concludes acute inflammatory demyelinating polyneuropathy.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Blood magnesium increased, Blood sodium normal, Blood thyroid stimulating hormone, Blood triglycerides normal, Blood urea normal
Clinical narrative: Complaints of numbness and tingling in the feet, generalized weakness that started several days prior to admission.  The patient's initial symptoms were mild but progressively worsened which prompted her to seek medical attention.  The patient did have a fall at home.  1/18/08 Reviewed hospital medical records which reveal patient experienced progressive generalized weakness & falls x 5-6 days prior to admit w/tingling in bilateral legs which progressed to involve tongue & fingers. Admitted 11/28-12/06/2007 to ICU for respiratory concerns.  On exam DTRs absent, unsteady gait, decreased sensation.  Neuro, Renal, Psych & ST consults done.  Tx w/plasmapheresis x 5.  While hospitalized, developed Bell's palsy.  Slow improvement & transferred to inpatient rehab 12/6-12/14/2007 for continued PT/OT.  Not much progress until received 2 more plasmapheresis treatments while in rehab, then progressed well.  D/C to home w/PT, Neuro & pcp f/u as outpatient. FINAL DX: Guillain-Barre syndrome. 1/24/08 Received EMG/NCS report of 11/29/07 which concludes acute inflammatory demyelinating polyneuropathy.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: C-reactive protein normal, Fall, Full blood count normal, Hypoaesthesia, Nuclear magnetic resonance imaging brain normal
Clinical narrative: Complaints of numbness and tingling in the feet, generalized weakness that started several days prior to admission.  The patient's initial symptoms were mild but progressively worsened which prompted her to seek medical attention.  The patient did have a fall at home.  1/18/08 Reviewed hospital medical records which reveal patient experienced progressive generalized weakness & falls x 5-6 days prior to admit w/tingling in bilateral legs which progressed to involve tongue & fingers. Admitted 11/28-12/06/2007 to ICU for respiratory concerns.  On exam DTRs absent, unsteady gait, decreased sensation.  Neuro, Renal, Psych & ST consults done.  Tx w/plasmapheresis x 5.  While hospitalized, developed Bell's palsy.  Slow improvement & transferred to inpatient rehab 12/6-12/14/2007 for continued PT/OT.  Not much progress until received 2 more plasmapheresis treatments while in rehab, then progressed well.  D/C to home w/PT, Neuro & pcp f/u as outpatient. FINAL DX: Guillain-Barre syndrome. 1/24/08 Received EMG/NCS report of 11/29/07 which concludes acute inflammatory demyelinating polyneuropathy.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia, Total cholesterol/HDL ratio normal, Vitamin B12 normal
Clinical narrative: Complaints of numbness and tingling in the feet, generalized weakness that started several days prior to admission.  The patient's initial symptoms were mild but progressively worsened which prompted her to seek medical attention.  The patient did have a fall at home.  1/18/08 Reviewed hospital medical records which reveal patient experienced progressive generalized weakness & falls x 5-6 days prior to admit w/tingling in bilateral legs which progressed to involve tongue & fingers. Admitted 11/28-12/06/2007 to ICU for respiratory concerns.  On exam DTRs absent, unsteady gait, decreased sensation.  Neuro, Renal, Psych & ST consults done.  Tx w/plasmapheresis x 5.  While hospitalized, developed Bell's palsy.  Slow improvement & transferred to inpatient rehab 12/6-12/14/2007 for continued PT/OT.  Not much progress until received 2 more plasmapheresis treatments while in rehab, then progressed well.  D/C to home w/PT, Neuro & pcp f/u as outpatient. FINAL DX: Guillain-Barre syndrome. 1/24/08 Received EMG/NCS report of 11/29/07 which concludes acute inflammatory demyelinating polyneuropathy.
Age: 60.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Went to Emergency room with redness, swelling, fever at site of pneumococcal vaccine.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Injected limb mobility decreased, Oedema peripheral, Pain in extremity, Skin warm
Clinical narrative: Rt arm was red, hot, swollen night of vaccination. Remained red, hot, swollen & painful for 2 weeks.  Redness, heat & swelling gone after 2 weeks but remains painful to move or use R arm to present date.
Age: 5.0
Sex: M
Vaccine: FLU3, VARCEL
Symptoms: Abnormal behaviour, Blood test, Computerised tomogram, Convulsion, Cyanosis
Clinical narrative: Vaccines were administered at approximately 10:10 am. Sister received vaccines. When leaving, patient walked into the wall. His body was rigid and he had some jerking motions to his extremities, He slumped to the floor against the wall after hitting his face and head. His face, lips, gums, anad tongue were blue. Patient was not responding. Pulse 62. Positioned for a patient airway. O2 at 2 liters/min. At 10:25 am .2ml. of epinephrine was given, Patient opened his eyes, but wasn't talking. He was incontinent of stool and the estimated time of seizure activity was 30 seconds. 911 was called. At 10:26 am pulse 72, BP 68/41, Resp. 22. Was pale. Alert and talking. Remembers only that his head started to hurt. Lungs clear. Pulse oximeter 98%. Ambulance arrived. Taken to the emergency room. Mom reported patient was all right. Became light-headed and fell. No allergic reaction. CAT scan ok.
Age: 5.0
Sex: M
Vaccine: FLU3, VARCEL
Symptoms: Dizziness, Dyskinesia, Face injury, Faecal incontinence, Fall
Clinical narrative: Vaccines were administered at approximately 10:10 am. Sister received vaccines. When leaving, patient walked into the wall. His body was rigid and he had some jerking motions to his extremities, He slumped to the floor against the wall after hitting his face and head. His face, lips, gums, anad tongue were blue. Patient was not responding. Pulse 62. Positioned for a patient airway. O2 at 2 liters/min. At 10:25 am .2ml. of epinephrine was given, Patient opened his eyes, but wasn't talking. He was incontinent of stool and the estimated time of seizure activity was 30 seconds. 911 was called. At 10:26 am pulse 72, BP 68/41, Resp. 22. Was pale. Alert and talking. Remembers only that his head started to hurt. Lungs clear. Pulse oximeter 98%. Ambulance arrived. Taken to the emergency room. Mom reported patient was all right. Became light-headed and fell. No allergic reaction. CAT scan ok.
Age: 5.0
Sex: M
Vaccine: FLU3, VARCEL
Symptoms: Head injury, Headache, Muscle rigidity, Oxygen supplementation, Pallor
Clinical narrative: Vaccines were administered at approximately 10:10 am. Sister received vaccines. When leaving, patient walked into the wall. His body was rigid and he had some jerking motions to his extremities, He slumped to the floor against the wall after hitting his face and head. His face, lips, gums, anad tongue were blue. Patient was not responding. Pulse 62. Positioned for a patient airway. O2 at 2 liters/min. At 10:25 am .2ml. of epinephrine was given, Patient opened his eyes, but wasn't talking. He was incontinent of stool and the estimated time of seizure activity was 30 seconds. 911 was called. At 10:26 am pulse 72, BP 68/41, Resp. 22. Was pale. Alert and talking. Remembers only that his head started to hurt. Lungs clear. Pulse oximeter 98%. Ambulance arrived. Taken to the emergency room. Mom reported patient was all right. Became light-headed and fell. No allergic reaction. CAT scan ok.
Age: 5.0
Sex: M
Vaccine: FLU3, VARCEL
Symptoms: Tongue discolouration, Unresponsive to stimuli
Clinical narrative: Vaccines were administered at approximately 10:10 am. Sister received vaccines. When leaving, patient walked into the wall. His body was rigid and he had some jerking motions to his extremities, He slumped to the floor against the wall after hitting his face and head. His face, lips, gums, anad tongue were blue. Patient was not responding. Pulse 62. Positioned for a patient airway. O2 at 2 liters/min. At 10:25 am .2ml. of epinephrine was given, Patient opened his eyes, but wasn't talking. He was incontinent of stool and the estimated time of seizure activity was 30 seconds. 911 was called. At 10:26 am pulse 72, BP 68/41, Resp. 22. Was pale. Alert and talking. Remembers only that his head started to hurt. Lungs clear. Pulse oximeter 98%. Ambulance arrived. Taken to the emergency room. Mom reported patient was all right. Became light-headed and fell. No allergic reaction. CAT scan ok.
Age: 31.0
Sex: M
Vaccine: TYP
Symptoms: Rash erythematous
Clinical narrative: Patient noticed diffuse red patches on trunk of body primarily on chest and stomach.  Symptoms noticed approx 24 hours following vaccination. Patient took otc Benadryl with no improvement of symptoms.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Eye swelling, Swelling face
Clinical narrative: Received vaccine at 5pm on 1-2-08. Next morning when my daughter awoke at 5:30am, her face was red and swollen. Even around her eyes were swollen. It looked like a sunburn. No other symptoms, gave Benadryl, still seems to have it. Called her doctor, was told to just keep giving Benadryl.
Age: 57.0
Sex: M
Vaccine: FLUX
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood bilirubin, Blood creatinine normal, Blood potassium decreased
Clinical narrative: Presented to the emergency room with a chief complaint of weakness and tingling in the extremities for 3 days.  It started with tingling and numbness in his hands, followed by foot.  It involves all his fingers up to just below shoulder, and also his toes.  Feels that he is in balance.  He also complains of mild headache.  Denies any history of dysarthria, visual changes.  He had a recent vaccination a couple of weeks ago, prior to his symptoms.  No history of any upper respiratory tract infection. 1.  Guillain-Barre syndrome. His EMG was abnormal, consistent with demyelinating neuropathy.  He had a spinal tap, which revealed elevated protein.  He was started on plasmapheresis on 10/27/07. He had a pleural catheter placed by Nephrology.  So far, he received 5 plasmapheresis.  His symptoms are better.  He is actively participating in physical therapy. 2.  Hypertension.  His blood pressure was elevated in the hospital.  He was started on Norvasc.  Will continue Norvasc 10 mg p.o. daily.  Will avoid ACE inhibitors as he is on plasmapheresis. 3.  Nonobstructive 10-mm left renal mid pole calculus. Asymptomatic. 4.  GERD.  He was started on Prilosec. 1/18/08-records received for DOS 10/24-11/2/07-DC DX: Guillain-Barre syndrome. Hypertension. GERD, nonobstructive 10-mm left renal mid pole calculus. Presented to ER with C/O weakness and tingling in extremities for 3 days. Tingling began then followed with numbness in hands, followed by foot. Involves all his fingers and up to shoulders and toes. Headache. Treated with plasmapheresis. Transferred to inpatient rehab.  Ongoing paresthesias. Significant weakness initially, requiring hospitalization and several months of therapy and time off work. Now recovering from GUILLAIN-BARRE syndrome and effects. Now complete recovery except for mild fatuge and paresthesis.
Age: 57.0
Sex: M
Vaccine: FLUX
Symptoms: Blood sodium normal, Blood urea increased, CSF protein increased, Chest X-ray normal, Computerised tomogram abnormal
Clinical narrative: Presented to the emergency room with a chief complaint of weakness and tingling in the extremities for 3 days.  It started with tingling and numbness in his hands, followed by foot.  It involves all his fingers up to just below shoulder, and also his toes.  Feels that he is in balance.  He also complains of mild headache.  Denies any history of dysarthria, visual changes.  He had a recent vaccination a couple of weeks ago, prior to his symptoms.  No history of any upper respiratory tract infection. 1.  Guillain-Barre syndrome. His EMG was abnormal, consistent with demyelinating neuropathy.  He had a spinal tap, which revealed elevated protein.  He was started on plasmapheresis on 10/27/07. He had a pleural catheter placed by Nephrology.  So far, he received 5 plasmapheresis.  His symptoms are better.  He is actively participating in physical therapy. 2.  Hypertension.  His blood pressure was elevated in the hospital.  He was started on Norvasc.  Will continue Norvasc 10 mg p.o. daily.  Will avoid ACE inhibitors as he is on plasmapheresis. 3.  Nonobstructive 10-mm left renal mid pole calculus. Asymptomatic. 4.  GERD.  He was started on Prilosec. 1/18/08-records received for DOS 10/24-11/2/07-DC DX: Guillain-Barre syndrome. Hypertension. GERD, nonobstructive 10-mm left renal mid pole calculus. Presented to ER with C/O weakness and tingling in extremities for 3 days. Tingling began then followed with numbness in hands, followed by foot. Involves all his fingers and up to shoulders and toes. Headache. Treated with plasmapheresis. Transferred to inpatient rehab.  Ongoing paresthesias. Significant weakness initially, requiring hospitalization and several months of therapy and time off work. Now recovering from GUILLAIN-BARRE syndrome and effects. Now complete recovery except for mild fatuge and paresthesis.
Age: 57.0
Sex: M
Vaccine: FLUX
Symptoms: Demyelinating polyneuropathy, Electromyogram abnormal, Gastrooesophageal reflux disease, Guillain-Barre syndrome, Haemoglobin increased
Clinical narrative: Presented to the emergency room with a chief complaint of weakness and tingling in the extremities for 3 days.  It started with tingling and numbness in his hands, followed by foot.  It involves all his fingers up to just below shoulder, and also his toes.  Feels that he is in balance.  He also complains of mild headache.  Denies any history of dysarthria, visual changes.  He had a recent vaccination a couple of weeks ago, prior to his symptoms.  No history of any upper respiratory tract infection. 1.  Guillain-Barre syndrome. His EMG was abnormal, consistent with demyelinating neuropathy.  He had a spinal tap, which revealed elevated protein.  He was started on plasmapheresis on 10/27/07. He had a pleural catheter placed by Nephrology.  So far, he received 5 plasmapheresis.  His symptoms are better.  He is actively participating in physical therapy. 2.  Hypertension.  His blood pressure was elevated in the hospital.  He was started on Norvasc.  Will continue Norvasc 10 mg p.o. daily.  Will avoid ACE inhibitors as he is on plasmapheresis. 3.  Nonobstructive 10-mm left renal mid pole calculus. Asymptomatic. 4.  GERD.  He was started on Prilosec. 1/18/08-records received for DOS 10/24-11/2/07-DC DX: Guillain-Barre syndrome. Hypertension. GERD, nonobstructive 10-mm left renal mid pole calculus. Presented to ER with C/O weakness and tingling in extremities for 3 days. Tingling began then followed with numbness in hands, followed by foot. Involves all his fingers and up to shoulders and toes. Headache. Treated with plasmapheresis. Transferred to inpatient rehab.  Ongoing paresthesias. Significant weakness initially, requiring hospitalization and several months of therapy and time off work. Now recovering from GUILLAIN-BARRE syndrome and effects. Now complete recovery except for mild fatuge and paresthesis.